Intuitive Surgical, Inc. ISRG is announcing its fourth-quarter earnings on Thursday. Wall Street expects $1.79 in EPS and $2.25 billion in revenues as the company reports after market hours.
The stock is up 63.75% over the past year, 16.06% YTD. Intuitive Surgical enters earnings season at record highs, with shares recently hitting an all-time high of $615.99.
The company’s expansion in southern Europe, acquiring da Vinci and Ion distribution businesses, strengthens its direct presence and customer reach. CEO Gary Guthart highlighted the move as key to deepening market understanding. With Intuitive Surgical trading at peak levels, investors will be watching earnings for signs of continued growth and market penetration.
Read More: Intuitive Surgical Expands Direct Reach: Plans Acquiring Key European da Vinci And Ion Distribution Businesses
Let’s look at what the charts indicate for Intuitive Surgical stock and how the stock currently maps against Wall Street estimates.
Intuitive Surgical stock is demonstrating strong bullish momentum, with its share price of $610.45 trading well above key moving averages.
Chart created using Benzinga Pro
The stock remains above its eight-, 20- and 50-day exponential moving averages, reinforcing a solid uptrend and consistent buying pressure. Additionally, Intuitive Surgical stock is comfortably positioned above its eight-day ($574.69), 20-day ($549.32), 50-day ($543.34) and 200-day ($469.79) simple moving averages, all of which generate bullish signals.
The MACD (moving average convergence/divergence) indicator at 16.28 further supports the stock’s upward trajectory, while the RSI (relative strength index) at 76.65 suggests Intuitive Surgical is approaching overbought levels, potentially leading to near-term consolidation.
The sustained technical strength indicates growing investor confidence, with momentum traders likely to stay engaged as long as Intuitive Surgical holds above these key support levels.
With buying pressure intact, long-term investors may see further upside, but a short-term pullback could provide better entry opportunities.
Ratings & Consensus Estimates: The consensus analyst rating on Intuitive Surgical stock stands at a Buy currently with a price target of $478.48. The latest analyst ratings from Truist, Citigroup and Wells Fargo imply a 5.23% upside for Intuitive Surgical, with an average price target of $636.67.
ISRG Price Action: Intuitive Surgical stock was trading at $608.33 at the time of publication Thursday.
Read Next:
Photo: Courtesy of Intuitive Surgical
Market News and Data brought to you by Benzinga APIs